COLL
Collegium Pharmaceutical Inc
NASDAQ: COLL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$33.76
+2.90% today
Updated 2026-04-29
Market cap
$1.09B
P/E ratio
19.51
P/S ratio
1.40x
EPS (TTM)
$1.73
Dividend yield
—
52W range
$27 – $51
Volume
0.6M
Collegium Pharmaceutical Inc (COLL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+4.7%
Last 4 quarters
Revenue YoY growth
+12.9%
Most recent quarter
EPS YoY growth
+15.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+8.8%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+18.0%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $2.04 | -4.7% | $45.75 | $41.67 | -8.9% |
| 2025-11-06 | $2.25 | +19.7% | $35.85 | $42.30 | +18.0% |
| 2025-08-07 | $1.68 | +1.2% | $29.75 | $34.93 | +17.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $2.14 | $2.04 | -4.7% | $205.45M | +12.9% |
| 2025-09-30 | $1.88 | $2.25 | +19.7% | $209.36M | +31.4% |
| 2025-06-30 | $1.66 | $1.68 | +1.2% | $188.00M | +29.4% |
| 2025-03-31 | $1.45 | $1.49 | +2.8% | $177.76M | +22.7% |
| 2024-12-31 | $1.54 | $1.77 | +15.1% | $181.95M | +21.5% |
| 2024-09-30 | $1.59 | $1.61 | +1.3% | $159.30M | +16.5% |
| 2024-06-30 | $1.49 | $1.62 | +8.7% | $145.28M | +7.2% |
| 2024-03-31 | $0.73 | $1.45 | +98.6% | $144.92M | — |
| 2023-12-31 | $0.66 | $0.82 | +24.2% | $149.75M | — |
| 2023-09-30 | $0.52 | $0.53 | +1.9% | $136.71M | — |
| 2023-06-30 | $0.29 | $0.34 | +17.2% | $135.55M | — |
Frequently asked questions
Has Collegium Pharmaceutical Inc beaten earnings estimates?
Collegium Pharmaceutical Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +4.7% over the last 4 quarters.
How does COLL stock react to earnings?
COLL stock has moved an average of +8.8% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Collegium Pharmaceutical Inc's revenue growth rate?
Collegium Pharmaceutical Inc reported year-over-year revenue growth of +12.9% in its most recent quarter, with EPS growing +15.3% year-over-year.